<div class="headers"><div>Figure 4. Percentage of subjects achieving blood pressure (BP) goals of <135/85 mm Hg and <130/80 mm Hg in nonobese (body mass index [BMI] <30 kg/m") and obese (BMI >30 kg/nr) subjects and subjects with and without the metabolic syndrome (MetS). A, aliskiren; AML, amlodipine.</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<thead>
<tr>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey;'> </th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>row/col</th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>1(A)</th>
</tr>
</thead>
<tbody>
<tr>
<td style='border-bottom: 2px solid grey; text-align: left;'>1</td>
<td style='border-bottom: 2px solid grey; text-align: left;'>1</td>
<td style='border-bottom: 2px solid grey; text-align: left;'><p style="" class="">Figure 4. Percentage of subjects achieving blood pressure (BP) goals of <135/85 mm Hg and <130/80 mm Hg in nonobese (body mass index [BMI] <30 kg/m") and obese (BMI >30 kg/nr) subjects and subjects with and without the metabolic syndrome (MetS). A, aliskiren; AML, amlodipine.</p></td>
</tr>
</tbody>
</table>
